MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.resmer.2026.101324

Медицинская библиотека · Respiratory medicine and research · 2026

First round of lung cancer screening among patients with atheromatous cardiovascular disease exposed to tobacco: a prospective cohort study.

Armand Elsa, Buton Clarisse, Caramella Caroline, Habert Paul, Hamouda Ilyes, Hamidou Zeinab, Issard Justin, Pradère Pauline, Dauriat Gaëlle, Mussot Sacha, Mitilian Delphine, Hache Océane, Lamrani Lilia, Pavec Jérôme Le, Zins Marc, Fidelle Marine, Pluvy Johan, Brioude Geoffrey, Todesco Alban, Lovato Jean-Baptiste, Tronchetti Julie, Dutau Herve, Greillier Laurent, Gaubert Jean-Yves, Jacquier Alexis, Trousse Delphine, D'journo Xavier-Benoit, Thomas Pascal-Alexandre, Fadel Elie, Haulon Stephan, Fabre Dominique, Ghostine Saïd, Kloeckner Martin, Abdayem Pamela, Kroemer Guido, Zitvogel Laurence, Besse Benjamin, Mercier Olaf, Boulate David

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Identification of populations eligible for lung cancer screening (LCS) is a priority question in this field. The primary objective of this study was to quantify lung cancer prevalence after a first round of LCS among patients with history of atheromatous cardiovascular disease (aCVD) and tobacco exposure.

METHODS

We performed a prospective bi-centric descriptive quantification of lung cancer prevalence among patients aged 45-75 years old with minimal history of 10 years of daily smoking and aCVD who underwent a chest computed tomography (CT) in an intend to screen. We also described lung cancer stage at diagnosis and treatments, we evaluated the eligibility of our population to the National Lung Screening Trial (NLST) and the Dutch-Belgian randomized controlled trial (NELSON) and described main quality metrics of LCS clinical path.

RESULTS

Among 505 participants who underwent a chest CT 159/505 (31%) did not met NLST nor NELSON eligibility criteria, 19/505 (3.8%) participants presented a positive screening. We diagnosed 16 cancers in 15 patients resulting in a LC prevalence of 2.97% (15/505). Among 16 lung cancers, 11 were stage I or II (75%). All patients with lung cancer received specific treatments including 12 surgeries alone, 2 surgeries with adjuvant systemic therapy, 1 radiation with systemic therapy and one systemic therapy alone; there was no postoperative severe morbidity (i.e. Clavien Dindo ≥ 3).

CONCLUSIONS

Our exploratory descriptive prospective study suggests that age 45-75 years-old, daily smoking for 10 years and aCVD may be evaluated in future studies as additional LCS eligibility criteria to existing LCS eligibility criteria.

Для цитирования: Armand Elsa, Buton Clarisse, Caramella Caroline, Habert Paul, Hamouda Ilyes, Hamidou Zeinab, Issard Justin, Pradère Pauline, Dauriat Gaëlle, Mussot Sacha, Mitilian Delphine, Hache Océane, Lamrani Lilia, Pavec Jérôme Le, Zins Marc, Fidelle Marine, Pluvy Johan, Brioude Geoffrey, Todesco Alban, Lovato Jean-Baptiste, Tronchetti Julie, Dutau Herve, Greillier Laurent, Gaubert Jean-Yves, Jacquier Alexis, Trousse Delphine, D'journo Xavier-Benoit, Thomas Pascal-Alexandre, Fadel Elie, Haulon Stephan, Fabre Dominique, Ghostine Saïd, Kloeckner Martin, Abdayem Pamela, Kroemer Guido, Zitvogel Laurence, Besse Benjamin, Mercier Olaf, Boulate David. First round of lung cancer screening among patients with atheromatous cardiovascular disease exposed to tobacco: a prospective cohort study.. Respiratory medicine and research. 2026. DOI: 10.1016/j.resmer.2026.101324.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.